Detection of redundant fusion transcripts as biomarkers or disease-specific therapeutic targets in breast cancer.
Asmann YW, Necela BM, Kalari KR, Hossain A, Baker TR, Carr JM, Davis C, Getz JE, Hostetter G, Li X, McLaughlin SA, Radisky DC, Schroth GP, Cunliffe HE, Perez EA, Thompson EA.
Asmann YW, et al.
Cancer Res. 2012 Apr 15;72(8):1921-8. doi: 10.1158/0008-5472.CAN-11-3142. Epub 2012 Apr 10.
Cancer Res. 2012.
PMID: 22496456